Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Four Development Riders Advance to Team Novo Nordisk's Pro Squad

Team Novo Nordisk, the world's first all-diabetes pro cycling team, is bringing four of its best development team athletes onto the men's pro squad for the 2019 season.


News provided by

Team Novo Nordisk

Oct 17, 2018, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Team Novo Nordisk - the world's first all-diabetes pro cycling team - is bringing four of its best development team athletes onto the men’s pro squad for the 2019 season.
Team Novo Nordisk - the world's first all-diabetes pro cycling team - is bringing four of its best development team athletes onto the men’s pro squad for the 2019 season.

ATLANTA, Oct. 17, 2018 /PRNewswire-PRWeb/ -- Team Novo Nordisk, the world's first all-diabetes pro cycling team, is bringing four of its best development team athletes—Swiss Oliver Behringer, Australians Declan Irvine and Sam Munday, and Uzbekistani Ulugbek Saidov onto the men's pro squad for the 2019 season. Behringer and Irvine have been racing as stagiaires with the team since August.

"Since the team's launch, our development program has always been a place where we've allocated significant resources because we know it is essential to invest in athletes with diabetes to help them develop so they can race at the professional level," Team Novo Nordisk CEO and co-founder Phil Southerland said. "The riders that come out of this program arrive as influential ambassadors for the diabetes community with an unwavering drive and enthusiasm to be in the professional ranks. All four of these athletes serve as further proof on how we are changing diabetes, and I am particularly excited to have our first Uzbekistani rider, Ulugbek Saidov, move up to the pro ranks."

“The riders that come from our development program arrive as influential ambassadors for the diabetes community. All of these athletes serve as further proof on how we are changing diabetes,” Team Novo Nordisk CEO and co-founder Phil Southerland said.

Post this

All four riders have raced at least two seasons as part of Team Novo Nordisk's development pipeline, and through hard work and dedication they've made significant progress and earned their spots on the pro squad. Team Novo Nordisk already announced Behringer and Irvine racing as stagiaires.

"Moving four riders up to the pro team proves the continued success of our pipeline. All year long we actively recruit new athletes and feel proud when their hard work pays off and earns them a professional contract," Team Novo Nordisk General Manager Vassili Davidenko said. "Ulugbek has solid climbing potential and Sam is an all-around rider. Initially, our goal is for them to work closely with our coaches and sports directors to continue improving their skills. We hope to start seeing results from them in two to three years from now."

Australian Sam Munday began racing at 15, four years after he was diagnosed with type 1 diabetes. He grew up with supportive parents and an encouraging healthcare team that reassured him to continue leading an active childhood after his diagnosis. Munday discovered Team Novo Nordisk through a diabetes educator who put him in touch with former pro rider Justin Morris. Munday soon attended one of the team's Talent ID programs in Atlanta, GA and earned a place on Team Novo Nordisk's development squad where he has raced for the past two years.

"I am extremely honored, excited and proud to pull on the pro jersey next season. It means so much to me to represent the team at the highest level and pursue my career as a professional athlete, all while representing the millions of people with type 1 diabetes around the world," the 19-year-old Munday said. "My goals for 2019 are to learn as much as possible from my teammates, improve my time trialing skills, and develop my physical strengths, positive mind and overall well-being while enjoying every exciting opportunity that gets thrown my way."

The 22-year-old Ulugbek Saidov hails from Tashkent, Uzbekistan and will be Team Novo Nordisk first professional rider from Central Asia. He was diagnosed with type 1 diabetes when he was nine years old. Tashkent is home to the Queen Sport Project, a cycling club designed for exclusively for youth with diabetes. Saidov joined the unique project when he was 15 and attended one of Team Novo Nordisk's talent ID camps the following year. Initially, he raced for Team Novo Nordisk's junior team. Through motivation and dedication, Saidov improved on both his diabetes management and bike handling skills and earned a spot on Team Novo Nordisk's development squad in 2017.

"I've been striving to move up to the pro team and I am beyond proud to represent Team Novo Nordisk in the pro ranks which I recognize comes with a big responsibility," Saidov said. "These past few years have played a significant role in helping me form a strong foundation in cycling and diabetes management. I know this first year won't be easy, but I'm focused on every detail to learn and grow in pro cycling and my personal development."

All athletes throughout Team Novo Nordisk's pipeline race with type 1 diabetes. Since its launch in December 2012, the organization has focused heavily on identifying and developing athletes from around the world with diabetes through its talent ID camps, junior team, and development team.

"I've been incredibly impressed with Ulugbek's development over the years; he serves as inspiration for everyone with diabetes in Uzbekistan and the effectiveness of the Queen Sport Project," Southerland said. "Sam is mature beyond his years and genuinely is a great human being. He is a fighter in the races and I'm excited to see how he develops."

Team Novo Nordisk will announce its full 2019 roster in a separate announcement.

About Team Novo Nordisk
Team Novo Nordisk is a global all-diabetes sports team of cyclists spearheaded by the world's first all-diabetes UCI Professional Continental cycling team. In 2012, Phil Southerland, co-founder and CEO of the team, and global healthcare company Novo Nordisk, came together to create Team Novo Nordisk, based on a shared vision to inspire, educate and empower people around the world affected by diabetes. For more information, go to http://www.teamnovonordisk.com.

Media Contact:
Fitzalan Crowe
Fitzalan.crowe(at)teamnovonordisk(dot)com
T: +1-703-596-2020 (U.S.)

SOURCE Team Novo Nordisk

Related Links

www.teamnovonordisk.com

Modal title

The 22-year-old Ulugbek Saidov hails from Tashkent, Uzbekistan and will be Team Novo Nordisk first professional rider from Central Asia.
The 22-year-old Ulugbek Saidov hails from Tashkent, Uzbekistan and will be Team Novo Nordisk first professional rider from Central Asia.
Australian Sam Munday began racing at 15, four years after he was diagnosed with type 1 diabetes
Australian Sam Munday began racing at 15, four years after he was diagnosed with type 1 diabetes
The 22-year-old Ulugbek Saidov hails from Tashkent, Uzbekistan and will be Team Novo Nordisk first professional rider from Central Asia. Australian Sam Munday began racing at 15, four years after he was diagnosed with type 1 diabetes

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.